AVROBIO, Inc. (AVRO) financial statements (2021 and earlier)

Company profile

Business Address ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments260187126
Cash and cash equivalents260187126
Receivables000
Prepaid expense110
Other current assets011
Other undisclosed current assets672
Total current assets:267196130
Noncurrent Assets
Property, plant and equipment343
Restricted cash and investments0  
Other noncurrent assets011
Total noncurrent assets:453
TOTAL ASSETS:271201133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities161411
Accounts payable343
Accrued liabilities14108
Deferred rent credit0  
Total current liabilities:171411
Noncurrent Liabilities
Liabilities, other than long-term debt001
Deferred rent credit001
Total noncurrent liabilities:001
Total liabilities:171511
Stockholders' equity
Stockholders' equity attributable to parent254186122
Common stock000
Additional paid in capital519331194
Accumulated deficit(264)(145)(72)
Total stockholders' equity:254186122
TOTAL LIABILITIES AND EQUITY:271201133

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(120)(76)(46)
Operating loss:(120)(76)(46)
Nonoperating income (expense)13(0)
Investment income, nonoperating130
Other nonoperating expense(0)(0)(0)
Net loss attributable to parent:(120)(73)(46)
Preferred stock dividends and other adjustments  (2)
Net loss available to common stockholders, diluted:(120)(73)(49)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(120)(73)(46)
Comprehensive loss, net of tax, attributable to parent:(120)(73)(46)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: